Rüstung: Tschechischer Munitionskonzern CSG nimmt Gewinnprognose zurück – Aktie bricht ein
CSG kappt seine Gewinnprognose, weil die Preise für gewöhnliche Munition fallen. Der Auftragsbestand hat zwar einen Rekordwert erreicht – aber die Margen sind gering.
Munich – The Czech arms firm CSG has had to lower its profit forecast for the current year due to falling prices for standard ammunition, which is becoming less in demand compared to longer-range munitions, the company announced on Wednesday in Amsterdam where it is listed. Additionally, lower-margin armored business now makes up a larger portion of the business.
Consequently, the profit margin for 2026 is expected to be around 21 percent, instead of the previously anticipated 24 to 25 percent. The revenue forecast remains unchanged at 7.4 to 7.6 billion euros. The CSG stock fell by 17.7 percent. Despite a six percent increase in revenue to 4.76 billion euros in the first nine months of the year, the adjusted profit before interest and taxes (EBIT) only grew by 0.4 percent to 1.1 billion euros, resulting in a 23.1 percent return.
By the end of September, CSG had reached a record order backlog of 18 billion euros, a 3 billion euro increase since the beginning of the year. CSG has also acquired a 9.9 percent stake in the Bavarian specialty chemicals company Alzchem, which produces nitroguanidine for explosives, and has access to up to 25 percent of its shares.
The Czech group had also been approached as a potential buyer for a share in the German competitor KNDS. More: KNDS aims to significantly increase production in Germany – "Needs two potential partners."
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
